Echinochrome A Attenuates Cerebral Ischemic Injury through Regulation of Cell Survival after Middle Cerebral Artery Occlusion in Rat.
Ran KimDaeun HurHyoung Kyu KimJin HanNatalia P MishchenkoSergey A FedoreyevValentin A StonikWoochul ChangPublished in: Marine drugs (2019)
Of late, researchers have taken interest in alternative medicines for the treatment of brain ischemic stroke, where full recovery is rarely seen despite advanced medical technologies. Due to its antioxidant activity, Echinochrome A (Ech A), a natural compound found in sea urchins, has acquired attention as an alternative clinical trial source for the treatment of ischemic stroke. The current study demonstrates considerable potential of Ech A as a medication for cerebral ischemic injury. To confirm the effects of Ech A on the recovery of the injured region and behavioral decline, Ech A was administered through the external carotid artery in a rat middle cerebral artery occlusion model after reperfusion. The expression level of cell viability-related factors was also examined to confirm the mechanism of brain physiological restoration. Based on the results obtained, we propose that Ech A ameliorates the physiological deterioration by its antioxidant effect which plays a protective role against cell death, subsequent to post cerebral ischemic stroke.
Keyphrases
- middle cerebral artery
- cerebral ischemia
- subarachnoid hemorrhage
- cell death
- clinical trial
- internal carotid artery
- atrial fibrillation
- oxidative stress
- healthcare
- brain injury
- blood brain barrier
- white matter
- poor prognosis
- mouse model
- acute myocardial infarction
- open label
- working memory
- study protocol
- stem cells
- left ventricular
- coronary artery disease
- bone marrow
- double blind